Simon Feys

🦋 🇧🇪MD, PhD, resident internal medicine, interested in viral-associated pulmonary aspergillosis 🦠🍄🫁 pianist 🎹 cycling amateur 🚴‍♂️ dad 👶

[Simon Feys @s_feys]

🦠 🍄 🫁
Our Review on influenza- and COVID-19-associated pulmonary aspergillosis is out now in @LancetRespirMed !
Thread below! 🧵

Link to Lancet (free log-in required): https://t.co/f3bgKCcdlx

Free link (no log-in required): https://t.co/nBB0u7DMXw

[Simon Feys @s_feys]

Proud to see our review on viral reactivations and fungal infections in non-resolving lung injury featured as Paper of the Day by CCR!
@lenn_maessen @JannesHeylen @Acute_Pulmo_Med

[Critical Care Reviews @CritCareReviews]

Today's Paper of the Day is:

Viral reactivations and fungal infections in nonresolving ARDS

https://t.co/JKgcYjlUQ5

Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2025

[Critical Care Reviews @CritCareReviews]

Viral reactivations and fungal infections in nonresolving acute respiratory distress syndrome

CCR Journal Watch
https://t.co/Sp06oA6IDG

[Martin Hoenigl🇺🇦🇦🇹 @martinhoenigl]

Kickoff meeting for the

🌌Galectin-3 targeted antifungal prophylaxis in ICU influenza (GALActIC)🌌

https://t.co/GS97plO8Yz project at @UZLeuven

Incredibly productive meeting with the Galactic team @carvalho_ago @s_feys @eurconfmedmycol @MSG_ERC

[Simon Feys @s_feys]

@criticcaredoc @FWOVlaanderen @KU_Leuven @UZLeuven @HdmFun Thanks Jan, and thanks for the nice questions!

[Simon Feys @s_feys]

Looking back with extreme gratitude on the past four years, having defended my PhD thesis on virus-associated aspergillosis last Tuesday. I got to work with fantastic people (many of whom have become friends), both within and outside the fungal research community (1/4)

[Simon Feys @s_feys]

@chitinette @FWOVlaanderen @KU_Leuven @UZLeuven @HdmFun Thanks, and thanks for being there Carol!

[Simon Feys @s_feys]

@FWOVlaanderen @KU_Leuven @UZLeuven @HdmFun

[Simon Feys @s_feys]

And lastly thanks to my colleagues, friends, family and most of all to my wife Liedewij and my son Briek, for everything they’ve done and for making life beautiful (4/4)

[Simon Feys @s_feys]

@Swidergall_lab @Mark_Gresnigt Thanks Marc!

[Simon Feys @s_feys]

@DrVinay118 @Mark_Gresnigt I think it was, I can send you the file in a couple of days

[Simon Feys @s_feys]

Wonderful to see this important research on interferon gamma in influenza-associated aspergillosis published by my fantastic colleague and friend @SeldeslachtsL !

[Laura Seldeslachts @SeldeslachtsL]

🌟 Thrilled to announce the publication of our paper in #eBioMedicine #TheLancet! 🌟

Damping excessive viral-induced IFN-γ restores the impaired anti-Aspergillus immune response in influenza-associated pulmonary aspergillosis (IAPA). 🧫🦠

https://t.co/krEIziWxE4

[Simon Feys @s_feys]

@GermHunterMD @martinhoenigl Thanks Ilan, hope to soon bump into you at some conference again!

[Simon Feys @s_feys]

@martinhoenigl Thanks for coming Martin, I’m glad you enjoyed it!

[Simon Feys @s_feys]

@Mark_Gresnigt Thanks Mark!

[Sarah Dellière is on Bluesky 🦋 @sarah_delliere]

🆕 Interplay btw host humoral pattern recognition molecules controls undue immune responses against #Aspergillus fumigatus in @NatureComms

w/ @VAimanianda at @institutpasteur

👉 In long : https://t.co/MGcQcHkHbR
👇 In short 🧵 1/6 #pentraxin3 #immunity

[Simon Feys @s_feys]

@martinhoenigl @MatthiasEgger11 @IlievLab @atscommunity Thanks for the nice editorial @martinhoenigl !

[The Lancet Respiratory Medicine @LancetRespirMed]

📰New Review: Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients

Severe viral pneumonia affects several layers of the antifungal host response

Read more free here: https://t.co/f0CbItezFd

@s_feys

[Intensive Care Medicine @yourICM]

Pulmonary HSV & CMV in #COVID19 #ARDS
🦠HSV reactivations common; ⬆️ alveolar inflammation post reactivation: may hinder resolution of inflammation/injury? Alveolar sampling appropriate if non-resolving ARDS. Antivirals could enhance outcome
🦠CMV rare
🖇️ https://t.co/Ht2Nxh1CbJ